共 50 条
Association of DNA methylation, polymorphism and mRNA level of ALAS1 with antituberculosis drug-induced liver injury
被引:0
|作者:
Hao, Zhuolu
[1
]
Han, Bing
[1
]
Zhou, Xinyue
[1
]
Jian, Hongkai
[2
]
He, Xiaomin
[3
]
Lu, Lihuan
[4
]
Zhang, Meiling
[5
]
Pan, Hongqiu
[6
]
Yi, Honggang
[1
]
Tang, Shaowen
[1
]
机构:
[1] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 211166, Peoples R China
[2] Nanjing Med Univ, Dept Internal Med, Clin Med Coll 1, Nanjing 211166, Peoples R China
[3] Peoples Hosp Taixing, Dept Infect Dis, Taixing 225400, Peoples R China
[4] Second Peoples Hosp Changshu, Dept TB, Changshu 215500, Peoples R China
[5] Jiangsu Univ, Jurong Hosp, Dept Infect Dis, Jurong 212400, Peoples R China
[6] Jiangsu Univ, Peoples Hosp Zhenjiang 3, Dept TB, Zhenjiang 212021, Peoples R China
基金:
中国国家自然科学基金;
关键词:
ALAS1;
AT-DILI;
DNA methylation;
SNP;
synergistic effect;
HEPATOTOXICITY;
RIFAMPICIN;
D O I:
10.1080/14622416.2024.2392480
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Aim: To investigate the association of DNA methylation, genetic polymorphisms and mRNA level of aminolevulinate synthase 1 (ALAS1) with antituberculosis drug-induced liver injury (AT-DILI) risk. Methods: Based on a 1:1 matched case-control study with 182 cases and 182 controls, one CpG island and three single nucleotide polymorphisms (SNPs) were detected. ALAS1 mRNA level was detected in 34 samples. Results: Patients with methylation status were at high risk of AT-DILI (odds ratio: 1.567, 95% CI: 1.015-2.421, p = 0.043) and SNP rs352169 was associated with AT-DILI risk (GA vs. GG, odds ratio: 1.770, 95% CI: 1.101-2.847, p = 0.019). ALAS1 mRNA level in the cases was significantly lower than that in the controls (0.75 +/- 0.34 vs. 1.00 +/- 0.42, p = 0.021). Conclusion: The methylation status and SNP rs352169 of ALAS1 were associated with AT-DILI risk.
引用
收藏
页码:451 / 460
页数:10
相关论文